- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Burning pain secondary to clozapine use: a case report ; volume:14 ; number:1 ; day:23 ; month:10 ; year:2014 ; pages:1-4 ; date:12.2014
BMC psychiatry ; 14, Heft 1 (23.10.2014), 1-4, 12.2014
- Urheber
-
Linton, Bradley
- Beteiligte Personen und Organisationen
-
Fu, Rachel
MacDonald, Penny A.
Ganjavi, Hooman
SpringerLink (Online service)
- DOI
-
10.1186/s12888-014-0299-3
- URN
-
urn:nbn:de:1111-201607164523
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Linton, Bradley
- Fu, Rachel
- MacDonald, Penny A.
- Ganjavi, Hooman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clozapine-induced agranulocytosis
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients
Burning pain attacks and red skin in a young woman
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
Clozapine augmentation strategies - a systematic meta-review of available evidence: treatment options for clozapine resistance
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Application of Clozapine to aggressive patients
Dosage and side effects of clozapine
Burning
Secondary organic aerosol formation from biomass burning intermediates: phenol and methoxyphenols
Clozapine-induced agranulocytosis
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients
Burning pain attacks and red skin in a young woman
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
Clozapine augmentation strategies - a systematic meta-review of available evidence: treatment options for clozapine resistance
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Application of Clozapine to aggressive patients
Dosage and side effects of clozapine
Burning
Secondary organic aerosol formation from biomass burning intermediates: phenol and methoxyphenols
Clozapine-induced agranulocytosis
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients
Burning pain attacks and red skin in a young woman
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
Clozapine augmentation strategies - a systematic meta-review of available evidence: treatment options for clozapine resistance
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Application of Clozapine to aggressive patients
Dosage and side effects of clozapine
Burning